January 21, 2021
Hahn Resigns as Head of FDA, Dr. Janet Woodcock New Interim Chief
THURSDAY, Jan. 21, 2021 (HealthDay News) — Stephen Hahn, M.D., resigned as commissioner of the U.S. Food and Drug Administration on Wednesday. Hahn became head of the agency just weeks before the start of the COVID-19 pandemic and was widely criticized during the public health crisis, with accusations that he gave in to former President...
Disparities in Diabetes Biomarkers After the Affordable Care Act
In a study published in Medical Care, a team of researchers conducted a thorough racially-stratified analysis of diabetes patients before and after the Affordable Care Act (ACA). The study assessed change in biomarkers for diabetes, including HbA1c and low-density lipoprotein (LDL), over a two-year period before and after the Affordable Care Act. Of the study...
Stem Cell Transplant May Slow Disability in Multiple Sclerosis
THURSDAY, Jan. 21, 2021 (HealthDay News) — For patients with multiple sclerosis (MS), autologous hematopoietic stem cell transplantation (aHSCT) may prevent worsening of disability, according to a study published online Jan. 20 in Neurology. Giacomo Boffa, M.D., from the University of Genoa in Italy, and colleagues analyzed long-term outcomes after aHSCT in 210 patients with...
AI Algorithms May Fail to Detect Diabetic Retinopathy
THURSDAY, Jan. 21, 2021 (HealthDay News) — Artificial intelligence (AI)-based screening algorithms for diabetic retinopathy (DR) show significant performance differences, according to a study published online Jan. 5 in Diabetes Care. In an effort to evaluate the accuracy of seven AI algorithms from five companies, Aaron Y. Lee, M.D., from the University of Washington in...